News Column

DIRECTOR DEALINGS: Hikma Pharmaceuticals Chairman Exercises Options

May 29, 2014

Arvind Bhunjun

LONDON (Alliance News) - Hikma Pharmaceuticals PLC Thursday said Chairman Said Darwazah exercised options over 75,924 shares at no cost under a company share plan Thursday.

Following this transaction, Darwazah has a total holding of 11 million shares, which represents 5.51% stake in the firm.

Shares in the pharmaceutical company were trading 1.1% higher at 1,702.00 pence Thursday morning.

For more stories on investments and markets, please see HispanicBusiness' Finance Channel

Source: Alliance News

Story Tools Facebook Linkedin Twitter RSS Feed Email Alerts & Newsletters